Application 206867
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ATHENTIA NEXT | LEVONORGESTREL | TABLET;ORAL | 1.5MG | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50102-211 | EContra One-Step | Levonorgestrel | Afaxys Pharma, LLC | ANDA | Current |
| 50102-211 | EContra One-Step | Levonorgestrel | Afaxys Pharma, LLC | ANDA | Current |
| 50102-211 | EContra One-Step | Levonorgestrel | Afaxys Pharma, LLC | ANDA | Current |
| 50102-211 | EContra One-Step | Levonorgestrel | Afaxys Pharma, LLC | ANDA | Current |
| 58602-712 | Fem Choice morning after | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-712 | Fem Choice morning after | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-721 | Athentia Next | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-721 | Athentia Next | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-721 | Athentia Next | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-841 | Econ Morning After | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-841 | Econ Morning After | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 58602-841 | Econ Morning After | Levonorgestrel | Aurohealth LLC | ANDA | Current |
| 69953-515 | Morning After | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 69953-616 | PostDay One-Step | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 82791-532 | Julie | Levonorgestrel | Julie Products Inc. | ANDA | Current |
| 82791-538 | Julie | Levonorgestrel | Julie Products Inc. | ANDA | Current |